Procter & Gamble reported third quarter fiscal year 2026 net sales of $21.2 billion, up 7% year-over-year, and diluted EPS of $1.63, a 6% increase. Core EPS grew 3% to $1.59. The results surpassed analyst estimates for both revenue and earnings.

Key Highlights

  • Organic sales growth accelerated to 3%, surpassing expectations, driven by a 2% increase in volume and 1% from pricing.
  • The Beauty segment was a key contributor, delivering strong organic sales growth of 7% led by volume increases and favorable product mix.
  • P&G maintained its full-year guidance but noted it now expects fiscal 2026 EPS to be toward the lower end of the previously stated range, citing increased investments and cost headwinds.